How Australian researchers are moving towards a simple injection to treat SCID
Australian researchers have successfully used experimental gene therapy to treat a patient with severe combined immunodeficiency (SCID), also known as 'bubble boy disease'. The treatment involves correcting genetic mutations in a laboratory setting.
Why it matters
This represents a significant medical breakthrough in gene therapy, offering potential cures for rare, life-threatening genetic disorders.
Save You have reached your maximum number of saved items.
Remove items from your saved list to add more.
Gift Gift icon 0 / 3 No gift articles left
You've used all of your gift articles. 3 more will become available on the 1st of every month.
Share A A A It’s the tail end of the flu season, and hundreds of shoppers are milling around a food court, searching for a bite to eat.
Until recently, sitting among this lunchtime crowd could have killed Matthew Rozek.
Matthew Rozek was born with a rare inherited immune disorder sometimes known as “bubble boy disease”. Joe Armao “It’s a big adjustment,” says the 29-year-old, who recently became one of the first people in the world to receive an experimental gene therapy that he hopes will cure him of severe combined immunodeficiency (SCID) or “bubble boy disease”.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in